AMRN vs CME · rev $87.3M vs P/E 22, rev $3.59B
Amarin Corporation PLC (AMRN) versus CME Group Inc (CME) — a side-by-side from cached financials, not a winner call.
Amarin Corporation PLC (AMRN) is a drug manufacturers - general company listed on US.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Latest reported AMRN revenue for 2026-06-30 was $87.3M. Net income was -$18.2M. Revenue was up 93.5% from 2026-03-31 to 2026-06-30. AMRN currently screens at market cap $292.1M.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
AMRN currently screens at market cap $292.1M. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Not investment advice. Open the AMRN and CME stock pages for the full models.
Not investment advice.